Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer

被引:9
|
作者
Guan, Alice [1 ]
Shim, Janet K. [2 ]
Allen, Laura [1 ]
Kuo, Mei-Chin [1 ]
Lau, Kathie [1 ]
Loya, Zinnia [1 ]
Brooks, James D. [3 ]
Carroll, Peter R. [4 ]
Cheng, Iona [1 ]
Chung, Benjamin I. [3 ]
DeRouen, Mindy C. [1 ]
Frosch, Dominic L. [5 ]
Golden, Todd [1 ]
Leppert, John T. [3 ]
Lichtensztajn, Daphne Y. [1 ]
Lu, Qian [6 ]
Oh, Debora L. [1 ]
Sieh, Weiva [7 ]
Wadhwa, Michelle [1 ]
Gomez, Scarlett L. [1 ]
Shariff-Marco, Salma [1 ,8 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA
[3] Stanford Univ, Dept Urol, Stanford, CA USA
[4] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
[5] Sutter Hlth Palo Alto Med Fdn Res Inst, Ctr Hlth Syst Res, Palo Alto, CA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX USA
[7] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA
[8] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16 St, San Francisco, CA 94158 USA
来源
CANCER MEDICINE | 2023年 / 12卷 / 05期
基金
美国国家卫生研究院;
关键词
prostate cancer; psychosocial studies; quality of life; translational research; ACTIVE SURVEILLANCE; AFRICAN-AMERICAN; MEN; RACE; SPIRITUALITY; MANAGEMENT; GUIDELINES; RESIDENCE; CARCINOMA; SURVIVORS;
D O I
10.1002/cam4.5405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundFactors that influence prostate cancer treatment decisions are complex, multifaceted, and personal, and may vary by race/ethnicity. Although research has been published to quantify factors involved in decision-making, these studies have been limited to primarily white, and to a lesser extent, Black patients, and quantitative studies are limited for discerning the cultural and contextual processes that shape decision-making. MethodsWe conducted 43 semi-structured interviews with a racially and ethnically diverse sample of patients diagnosed with low- and very-low risk prostate cancer who had undergone treatment for their prostate cancer. Interviews were transcribed, independently coded, and analyzed to identify themes salient for decision-making, with attention to sociocultural differences. ResultsWe found racial and ethnic differences in three areas. First, we found differences in how socialized masculinity influenced patient's feelings about different treatment options. Second, we found that for some men, religion and spirituality alleviated anxiety associated with the active surveillance protocol. Finally, for racially and ethnically minoritized patients, we found descriptions of how historic and social experiences within the healthcare system influenced decision-making. ConclusionsOur study adds to the current literature by expounding on racial and ethnic differences in the multidimensional, nuanced factors related to decision-making. Our findings suggest that factors associated with prostate cancer decision-making can manifest differently across racial and ethnic groups, and provide some guidance for future research.
引用
收藏
页码:6307 / 6317
页数:11
相关论文
共 50 条
  • [21] EFFECTS OF 5-ALPHA REDUCTASE INHIBITOR USE IN MONITORED MEN WITH VERY-LOW RISK PROSTATE CANCER
    Ross, Ashley E.
    Feng Zhaoyong
    Pierorazio, Phillip M.
    Landis, Patricia
    Walsh, Patrick C.
    Carter, H. Ballentine
    Trock, Bruce J.
    Schaeffer, Edward M.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E657 - E658
  • [22] UPGRADING ON RADICAL PROSTATECTOMY SPECIMENS OF VERY LOW- AND LOW-RISK PROSTATE CANCER PATIENTS ON ACTIVE SURVEILLANCE: A POPULATION-LEVEL ANALYSIS
    Sayyid, Rashid
    Wilson, Brandon
    Benton, John
    Lodh, Atul
    Thomas, Eric
    Goldberg, Hanan
    Madi, Rabii
    Terris, Martha
    Wallis, Christopher
    Klaassen, Zachary
    JOURNAL OF UROLOGY, 2021, 206 : E887 - E888
  • [23] Upgrading on radical prostatectomy specimens of very low- and low-risk prostate cancer patients on active surveillance: A population-level analysis
    Sayyid, Rashid K.
    Wilson, Brandon
    Benton, John Z.
    Lodh, Atul
    Thomas, Eric F.
    Goldberg, Hanan
    Madi, Rabii
    Terris, Martha K.
    Wallis, Christopher J. D.
    Klaassen, Zachary
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (07): : E335 - E339
  • [24] Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management
    Kelly, Scott P.
    Van den Eeden, Stephen K.
    Hoffman, Richard M.
    Aaronson, David S.
    Lobo, Tania
    Luta, George
    Leimpter, Amethyst D.
    Shan, Jun
    Potosky, Arnold L.
    Taylor, Kathryn L.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 734 - 740
  • [25] Utilization of 17-gene biopsy-based genomics scores in treatment decisions for low- to intermediate-risk patients with prostate cancer.
    Katz, Aaron
    Mulcahy, Megan
    Rice, Jacquelyn
    Kosinski, Kaitlin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [26] Treatment Options for Patients with Low-risk-Prostate Cancer PREFERE- Study
    Ohlmann, C. -H.
    Bottke, D.
    Stoeckle, M.
    Albers, P.
    Schmidberger, H.
    Haerter, M.
    Kristiansen, G.
    Bussar-Maatz, R.
    Wiegel, T.
    ONKOLOGE, 2016, 22 (03): : 216 - 216
  • [27] Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review
    Rodrigues, George
    Yao, Xiaomei
    Loblaw, D. Andrew
    Brundage, Michael
    Chin, Joseph L.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2013, 7 (11-12): : 463 - 470
  • [28] ROLE OF THE PRIMARY CARE PROVIDER (PCP) IN THE CARE OF PATIENTS WITH LOW RISK PROSTATE CANCER: A QUALITATIVE STUDY
    Berger, Zackary
    Carter, H. B.
    Pollack, Craig E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S176 - S176
  • [29] Comparison of pathological data between prostate biopsy and radical prostatectomy specimen in patients with low to very low risk prostate cancer
    Lendinez-Cano, G.
    Alonso-Flores, J.
    Beltran-Aguitar, V.
    Cayuela, A.
    Salazar-Otero, S.
    Bachiller-Burgos, J.
    ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (08): : 482 - 487
  • [30] Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study
    Subramanian, Lalita
    Hawley, Sarah T.
    Skolarus, Ted A.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Chen, Jason
    Radhakrishnan, Archana
    CANCER MEDICINE, 2024, 13 (01):